Prevalence and Determinants of Diabetes Mellitus in 2338 Long-Term Dutch Childhood Cancer Survivors (DCCS-LATER2 Study)
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf078 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Melissa Bolier und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Section Endocrinology, Erasmus Medical Center, 3015 GD Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Cancer Survivors, Diabetes Mellitus, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Children Cancer-free Foundation, KiKaRoW, ODAS foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Diabetes mellitus (DM), a possible adverse effect of childhood cancer treatment, is strongly associated with cardiovascular disease and early mortality in adult childhood cancer survivors (CCS).
Objective
Here, we assess the prevalence and determinants of DM in our nationwide CCS cohort.
Methods
In this cross-sectional study, the prevalence of DM was assessed in 2338 CCS, using the Lifelines cohort (n = 132 226 adults with no history of cancer) as a reference. DM was defined through serum glucose measurement (fasting glucose ≥7.0 mmol/L or nonfasting ≥11.1 mmol/L) and/or self-report (previous diagnosis and/or medication use). Multivariable logistic regression models, adjusted for age, sex, and body mass index (BMI), were used to assess the cohort effect on the presence of DM. Multivariable logistic regression analysis was used to identify determinants of DM in CCS.
Results
Survivors (median age 34.7 years, median follow-up time 27.1 years) showed increased odds for hyperglycemia (aOR = 2.72; 95% CI, 2.06-3.59), previous DM diagnosis (aOR = 3.03; 95% CI, 2.33-3.95), and antidiabetic medication use (aOR = 2.94; 95% CI, 2.17-3.99), compared to the reference cohort. Age (OR = 4.32; 95% CI, 1.84-10.15, >35 vs 18-35 years), BMI (OR = 1.12; 95% CI, 1.08-1.16, per point), family history of DM (OR = 2.38; 95% CI, 1.51-3.76), prior abdominal/pelvic radiotherapy (OR = 4.19; 95% CI, 2.32-7.55), total body irradiation (OR = 14.31; 95% CI, 6.98-29.34), hypogonadism (OR = 2.40; 95% CI, 1.15-4.99), hypertension (OR = 1.71; 95% CI, 1.06-2.76), and dyslipidemia (OR = 3.81; 95% CI, 2.15-6.75) were associated with DM in CCS. A statistically significant interaction between age and sex on the development of DM in survivors was identified.
Conclusion
The identified 3-fold increased risk of DM in CCS, along with the clinically relevant and some modifiable determinants, underscores the importance of early risk-based screening and the exploration of lifestyle interventions in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Section Endocrinology, Erasmus Medical Center, 3015 GD Rotterdam, the Netherlands.
- Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, the Netherlands.
- Department of Biomedical Data Science, Section Medical Statistics, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
- Mathematical Institute Leiden University, 2333 CC Leiden, the Netherlands.
- Department of Clinical Chemistry, Erasmus Medical Center, 3015 GD Rotterdam, the Netherlands.
- Pediatric Oncology, Cancer Center Amsterdam, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, the Netherlands.
ORCID-Profile: Melissa Bolier, Marry M van den Heuvel-Eibrink, Sebastian J C M M Neggers
Förderung
- Children Cancer-free Foundation
- KiKaRoW
- ODAS foundation
- Dutch Ministry of Health, Welfare and Sport
- Dutch Ministry of Economic Affairs
- University Medical Center Groningen
- Groningen University
- Provinces in the North of the Netherlands
Zitieren
APA
Bolier, M., de Winter, D. T. C., Fiocco, M., van den Berg, S. A. A., Bresters, D., van Dulmen-den Broeder, E., van der Heiden-van der Loo, M., Hoefer, I., Janssens, G. O., Kremer, L. C. M., Loonen, J. J., Louwerens, M., van der Pal, H. J., Pluijm, S. M. F., Tissing, W. J. E., van Santen, H. M., de Vries, A. C. H., van der Lely, A. J., van den Heuvel-Eibrink, M. M., & Neggers, S. J. C. M. M. (2025). Prevalence and Determinants of Diabetes Mellitus in 2338 Long-Term Dutch Childhood Cancer Survivors (DCCS-LATER2 Study). The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf078
Vancouver
Bolier M, de Winter DTC, Fiocco M, van den Berg SAA, Bresters D, van Dulmen-den Broeder E, et al. Prevalence and Determinants of Diabetes Mellitus in 2338 Long-Term Dutch Childhood Cancer Survivors (DCCS-LATER2 Study). The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf078
BibTeX
@article{Bolier2025,
author = {Bolier, Melissa and de Winter, Demi T C and Fiocco, Marta and van den Berg, Sjoerd A A and Bresters, Dorine and van Dulmen-den Broeder, Eline and van der Heiden-van der Loo, Margriet and Hoefer, Imo and Janssens, Geert O and Kremer, Leontien C M and Loonen, Jacqueline J and Louwerens, Marloes and van der Pal, Heleen J and Pluijm, Saskia M F and Tissing, Wim J E and van Santen, Hanneke M and de Vries, Andrica C H and van der Lely, Aart-Jan and van den Heuvel-Eibrink, Marry M and Neggers, Sebastian J C M M},
title = {Prevalence and Determinants of Diabetes Mellitus in 2338 Long-Term Dutch Childhood Cancer Survivors (DCCS-LATER2 Study)},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf078}
}
EUVIMED